Holding(s) in Company
Eco Animal Health Group Plc
For filings with the FCA include the annex | Â | ||||||||||
For filings with issuer exclude the annex | |||||||||||
 | |||||||||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||||||||
 |  |  | |||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Eco Animal Health Group plc | ||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||
An acquisition or disposal of voting rights | Â |
x |
|||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | ||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | ||||||||||
An event changing the breakdown of voting rights | Â | ||||||||||
Other (please specify): | Â | Â | Â | ||||||||
3. Full name of person(s) subject to the notification obligation: iii |
 | Schroders plc | |||||||||
4. Full name of shareholder(s) (if different from 3.):iv |
 | ||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
17.12.15 | ||||||||||
6. Date on which issuer notified: | 18.12.15 | ||||||||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
From 14% - 13% |
8. Notified details: | |||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||||||||||||||||||||||||
Class/type of shares
|
 |
Situation previous to the triggering transaction |
 | Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||
Number of Shares |
 |
Number of Voting Rights |
Number of shares |
 |
Number of voting rights |
 | % of voting rights x | ||||||||||||||||||||||||||
 | Direct xi |  | Indirect xii | Direct |  | Indirect | |||||||||||||||||||||||||||
Ordinary
 GB0032036807 |
10,911,025 | 9,552,859 | 10,511,025 | N/A | 8,902,859 | N/A | 13.917% | ||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 |
Expiration date xiii |
 |
Exercise/ Conversion Period xiv |
 |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
 |
% of voting rights |
|||||||||||||||||||||||||
 |  |  |  |  | |||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||||||||||||||||||||
Type of financial instrument |
 | Exercise price | Expiration date xvii |  |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | Â | % of voting rights xix, xx | |||||||||||||||||||||||||
 |  |  |  |
 |
Nominal | Â | Delta | ||||||||||||||||||||||||||
 |  | ||||||||||||||||||||||||||||||||
 | |||||||||||||||||||||||||||||||||
Total (A+B+C) | |||||||||||||||||||||||||||||||||
Number of voting rights | Â | Percentage of voting rights | |||||||||||||||||||||||||||||||
8,902,859 | 13.917% |
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if applicable: xxi |
||||
Schroder Investment Management Limited 8,840,553 13.820% Â Schroder & Co. Limited 62,306 0.097% |
||||
 | ||||
Proxy Voting: | ||||
10. Name of the proxy holder: | Â | Â | ||
11. Number of voting rights proxy holder will cease to hold: |
 | |||
12. Date on which proxy holder will cease to hold voting rights: |
 | |||
 | ||||
13. Additional information: |
 | The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 63,837,685. | ||
14. Contact name: | Chloe Talbot | |||
15. Contact telephone number: | 020 7658 6000 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20151220005064/en/